Chantal Morel

3.0k total citations
58 papers, 1.5k citations indexed

About

Chantal Morel is a scholar working on Applied Microbiology and Biotechnology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chantal Morel has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Applied Microbiology and Biotechnology, 21 papers in Economics and Econometrics and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chantal Morel's work include Antibiotic Use and Resistance (22 papers), Pharmaceutical Economics and Policy (20 papers) and Malaria Research and Control (10 papers). Chantal Morel is often cited by papers focused on Antibiotic Use and Resistance (22 papers), Pharmaceutical Economics and Policy (20 papers) and Malaria Research and Control (10 papers). Chantal Morel collaborates with scholars based in United Kingdom, Switzerland and Germany. Chantal Morel's co-authors include David Evans, Jeremy A. Lauer, Elías Mossialos, Anne Mills, Samuel D. Shillcutt, Catherine Goodman, P. G. Coleman, Stephan Harbarth, David S.H. Bell and C. W. M. Whitty and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and PLoS Medicine.

In The Last Decade

Chantal Morel

54 papers receiving 1.4k citations

Peers

Chantal Morel

PHEOH

PPCH

AMB

Jasper Ogwal‐Okeng Uganda

Hellen Gelband United States

Precious Matsoso South Africa

Yoel Lubell Thailand

Trần Khánh Toàn Vietnam

Sadie Regmi United Kingdom

Chand Wattal India

Milena M. McLaughlin United States

Nimako Sarpong Ghana

Paul Waako Uganda

Jasper Ogwal‐Okeng Uganda

Chantal Morel

314 ×0.7

PHEOH

364 ×1.1

PPCH

430 ×1.4

AMB

129 ×0.5

150 ×0.6

Citations per year, relative to Chantal Morel Chantal Morel (= 1×) peers Jasper Ogwal‐Okeng

Countries citing papers authored by Chantal Morel

Since Specialization

Citations

This map shows the geographic impact of Chantal Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Morel more than expected).

Fields of papers citing papers by Chantal Morel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Morel. The network helps show where Chantal Morel may publish in the future.

Co-authorship network of co-authors of Chantal Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Morel. A scholar is included among the top collaborators of Chantal Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Morel. Chantal Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scudeller, Luigia, Tomislav Kostyanev, Jobiba Chinkhumba, et al.. (2025). Prevalence of Extended-Spectrum β-Lactamase-Producing Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae in Wastewater Effluent in Blantyre, Malawi. Antibiotics. 14(6). 562–562. 1 indexed citations

Mpundu, Mirfin, Luigia Scudeller, Tomislav Kostyanev, et al.. (2025). Economic costing methodologies for drug-resistant bacterial infections in humans in low-and middle-income countries: a systematic review. Health Economics Review. 15(1). 47–47.

Hermans, Lucas E., Chad M. Centner, Chantal Morel, et al.. (2023). Point-of-care diagnostics for infection and antimicrobial resistance in sub-Saharan Africa: A narrative review. International Journal of Infectious Diseases. 142. 106907–106907. 3 indexed citations

Morel, Chantal, et al.. (2021). Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options. Frontiers in Medicine. 8. 652638–652638. 7 indexed citations

Morel, Chantal, et al.. (2021). Market concentration of new antibiotic sales. The Journal of Antibiotics. 74(6). 421–423. 6 indexed citations

Colson, Abigail, Alec Morton, Christine Årdal, et al.. (2021). Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?. Value in Health. 24(12). 1828–1834. 20 indexed citations

Morel, Chantal, et al.. (2020). Lessons from COVID-19 on the role of the state and the market in providing early testing. Journal of Global Health. 10(2). 20330–20330. 3 indexed citations

Morel, Chantal & Suzanne Edwards. (2018). Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives. The Journal of Law Medicine & Ethics. 46(S1). 75–80. 3 indexed citations

Abbas, Mohamed, Daniela Pires, Alexandra Peters, et al.. (2018). Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review. Intensive Care Medicine. 44(10). 1679–1690. 8 indexed citations

10.

Pulcini, C., Chantal Morel, Evelina Tacconelli, et al.. (2017). Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clinical Microbiology and Infection. 23(11). 785–787. 74 indexed citations

11.

Morel, Chantal, Suzanne Edwards, & Stéphan Harbarth. (2017). Preserving the ‘commons’: addressing the sustainable use of antibiotics through an economic lens. Clinical Microbiology and Infection. 23(10). 718–722. 10 indexed citations

12.

Dach, Elodie von, Chantal Morel, Léonardo Pagani, et al.. (2017). Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective. Clinical Microbiology and Infection. 23(9). 659–666. 7 indexed citations

13.

Baraldi, Enrico, et al.. (2016). Exploring the Obstacles to Implementing Economic Mechanisms to Stimulate Antibiotic Research and Development. American Journal of Law & Medicine. 42(2-3). 451–486. 4 indexed citations

14.

Reidpath, Daniel D., Chantal Morel, Jeffrey W. Mecaskey, & Pascale Allotey. (2009). The Millennium Development Goals Fail Poor Children: The Case for Equity-Adjusted Measures. PLoS Medicine. 6(4). e1000062–e1000062. 38 indexed citations

15.

Morel, Chantal, Jeremy A. Lauer, & David Evans. (2005). Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ. 331(7528). 1299–1299. 235 indexed citations

16.

Boralévi, F., Sébastien Lepreux, Alexandre Boyer, et al.. (2003). Syringométaplasie eccrine épidermoïde et infection à cytomégalovirus : une observation. La Revue de Médecine Interne. 24(6). 394–398. 3 indexed citations

17.

Remme, J, Erik Blas, Lester Chitsulo, et al.. (2002). Strategic emphases for tropical diseases research: a TDR perspective. Trends in Parasitology. 18(10). 421–426. 86 indexed citations

18.

Oppenheimer, Lawrence, et al.. (2001). INFLUENCE OF AN EDUCATIONAL PROGRAM ON MEDICAL STUDENTS' ATTITUDES TO SUBSTANCE USE DISORDERS IN PREGNANCY. The American Journal of Drug and Alcohol Abuse. 27(3). 483–490. 48 indexed citations

19.

Morel, Chantal. (2000). Reaching Maturity — 25 Years of the TDR. Parasitology Today. 16(12). 522–528. 77 indexed citations

20.

Duhamel, Christophe, et al.. (1976). A case of intestinal fluke infection.. 5(15). 1005–1006. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact